Clinical Trials List
Protocol NumberPS1-01
Active
2023-09-01 - 2027-12-31
Phase I
Recruiting1
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-10E11.69
Type 2 diabetes mellitus with other specified complication
ICD-9250.82
Diabetes with other specified manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, uncontrolled
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
MING-CHE LIU
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
75 participants
-
Global
75 participants
